Document is current

Article History

Received: 1 April 2024

Accepted: 8 August 2024

First Online: 2 September 2024

Declarations

:

: We conducted the current study in accordance with the ethical standards outlined in the 1964 Declaration of Helsinki, its later amendments, or comparable ethical standards. Our study obtained approval from the Hasanuddin University Ethics Committee under the reference number 10261/UN4.14.1/TP.01.02/2022 on September 5, 2022. The Parigi Moutong Regency Government also granted permission for research on February 11, 2022, with the number 870/0130/BKPSDM. All potential participants have obtained verbal informed consent from their treating doctor. Again, before the data collection process, the researcher also confirmed their willingness to participate. After receiving information about this study, all potential participants must provide written consent to participate in this study. Notably, all participants also had the opportunity to ask questions before, during, and after data collection.

: Not applicable.

: MJP reports accepting grants and honoraria from a variety of pharmaceutical firms, including those engaged in the creation, manufacturing, and promotion of drugs for diabetes. However, this specific study was unrelated to any of the funds or honoraria. The other authors affirm that they have no competing interests in this specific study or topic matter. Nevertheless, we adhere to the journal’s requirements for the exchange of materials and data.